Optimizing prescription of chinese herbal medicine for unstable angina based on partially observable markov decision

Yan Feng1, Yu Qiu, Xuezhong Zhou

  • 1Department of General Practice, Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Insights

This study optimized Chinese herbal medicine prescriptions for unstable angina (UA) using a partially observable Markov decision process (POMDP) model. Key herbal combinations were identified for specific UA syndrome patterns, aiding future treatment development.

Area of Science:

  • Integrative and Complementary Medicine
  • Cardiovascular Medicine
  • Computational Medicine

Background:

  • Unstable angina (UA) management requires effective therapeutic strategies.
  • Traditional Chinese Medicine (TCM) offers complex herbal prescriptions for UA.
  • Objective evaluation of TCM prescriptions for UA is needed.

Purpose of the Study:

  • To optimize Chinese herbal medicine prescriptions for unstable angina (UA).
  • To apply a partially observable Markov decision process (POMDP) model for prescription optimization.
  • To identify effective herbal combinations for specific UA syndrome patterns.

Main Methods:

  • Utilized a partially observable Markov decision process (POMDP) model.
  • Performed data mining and analysis on hospitalized UA patients with qi deficiency, blood stasis, and turbid phlegm syndromes.
  • Objectively evaluated diagnosis and treatment data to optimize prescriptions.

Main Results:

  • Identified optimal herbal combinations for UA with specific syndrome elements.
  • Recommended Milkvetch Root + Tangshen + Indian Bread + Largehead Atractylodes Rhizome (ADR = 0.96630) for qi deficiency, blood stasis, and phlegm syndrome.
  • Provided other optimized prescriptions with associated ADR values for different syndrome combinations.

Conclusions:

  • The study provides initial optimized Chinese herbal medicine prescriptions for UA based on POMDP.
  • These optimized prescriptions can serve as a valuable reference for future UA treatment development in TCM.
  • The POMDP model offers a data-driven approach to refining TCM prescriptions.

Related Concept Videos

Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...